BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 18767953)

  • 1. Dendritic cell-based cancer vaccination: quo vadis?
    Dauer M; Schnurr M; Eigler A
    Expert Rev Vaccines; 2008 Sep; 7(7):1041-53. PubMed ID: 18767953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H; Shurin MR; Han B
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taming cancer by inducing immunity via dendritic cells.
    Palucka AK; Ueno H; Fay JW; Banchereau J
    Immunol Rev; 2007 Dec; 220():129-50. PubMed ID: 17979844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
    Tacken PJ; de Vries IJ; Torensma R; Figdor CG
    Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells as vectors for immunotherapy of cancer.
    Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
    Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.
    Liu G; Black KL; Yu JS
    Expert Rev Vaccines; 2006 Apr; 5(2):233-47. PubMed ID: 16608423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of dendritic cells in cancer immunotherapy.
    Nencioni A; Grünebach F; Schmidt SM; Müller MR; Boy D; Patrone F; Ballestrero A; Brossart P
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell-based immunotherapy.
    Osada T; Clay TM; Woo CY; Morse MA; Lyerly HK
    Int Rev Immunol; 2006; 25(5-6):377-413. PubMed ID: 17169781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration of dendritic cell based cancer vaccines: in vivo veritas?
    Adema GJ; de Vries IJ; Punt CJ; Figdor CG
    Curr Opin Immunol; 2005 Apr; 17(2):170-4. PubMed ID: 15766677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of tumour antigens by dendritic cells and challenges faced.
    Robson NC; Hoves S; Maraskovsky E; Schnurr M
    Curr Opin Immunol; 2010 Feb; 22(1):137-44. PubMed ID: 20116984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells in cancer immunotherapy.
    Gunzer M; Grabbe S
    Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DC-based cancer vaccines.
    Gilboa E
    J Clin Invest; 2007 May; 117(5):1195-203. PubMed ID: 17476349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-based cancer immunotherapies.
    Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine strategies to treat lymphoproliferative disorders.
    Radford KJ; Vari F; Hart DN
    Pathology; 2005 Dec; 37(6):534-50. PubMed ID: 16373232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current issues in delivering DCs for immunotherapy.
    Barratt-Boyes SM; Figdor CG
    Cytotherapy; 2004; 6(2):105-10. PubMed ID: 15203986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-based vaccines in breast and gynaecologic cancer.
    Hernando JJ; Park TW; Kuhn WC
    Anticancer Res; 2003; 23(5b):4293-303. PubMed ID: 14666641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells.
    Breckpot K; Heirman C; Neyns B; Thielemans K
    J Gene Med; 2004 Nov; 6(11):1175-88. PubMed ID: 15468193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer vaccines for established cancer: how to make them better?
    Andrews DM; Maraskovsky E; Smyth MJ
    Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reengineering dendritic cell-based anti-cancer vaccines.
    Koski GK; Cohen PA; Roses RE; Xu S; Czerniecki BJ
    Immunol Rev; 2008 Apr; 222():256-76. PubMed ID: 18364007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.